Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by quietobserveron Apr 11, 2019 3:40pm

209 Views

Post# 29614890

RE:RE:RE:On a day of doom and gloom

jayjay I don't think forward guidance will help if some analysts call Bullsh1t as they did with Contstellations CEO. We need some news to knock it out of the park instead of hitting the post all the time. It's almost laughable if it wasn't so sad looking at the way things line up for this company.
The bleak assessment of Canopy’s sales outlook contrasts with remarks last week from Constellation Brands Inc.’s (STZ) chief executive. Bill Newlands is calling for Canopy to hit $1 billion in annual sales next year. The U.S. beer and wine maker has a 38 per cent ownership stake in Canopy.

jayjay2020 wrote:

Daredevil1964 wrote: I agree, but, that 10 USD resistance at this limited volume will be impossible to break thru. We need the earnings anticipated beat tommorrow and an ER that backs that anticipation on Monday. If that happens, I do believe we may get a small run to the mid 14s to 15 CAD. Problem is I do not have a clue how long that price will hold. People will be cashing out in May, to return in October.

I think the forward guidance is the most important. Vic was not keen on providing forward numbers. I see Irwin willing to do so. He already called $1B for 2020. He has to pound that number home and guide onthe next Q as being amazing with more production coming on line, brand roll outs and some forcast on LATAM builds.